Vanessa Sze Theen Tee1,2, Phan Nguyen1,2, Hubertus Jersmann1,2, Dion Grosser3, Benjamin Crouch4, Brett Lorraine5, Chong Ghee Chew4. 1. School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. 2. Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 3. ChestCare, Adelaide, South Australia, Australia. 4. Department of Nuclear Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 5. SA Medical Imaging, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Abstract
BACKGROUND: Quantitative planar ventilation-perfusion (VQ) has a complementary role in target lobe selection for endobronchial valve lung volume reduction (EBV-LVR), especially in homogenous disease. We investigated a novel method of lung lobar quantitation using VQ single-photon emission computed tomography (SPECT) with computed tomography (CT) to generate a parameter called the ventilation-perfusion differential index (VQDI). AIM: The aim of this study was to validate VQDI as a parameter for target lobe selection in EBV-LVR against the gold standard test of quantitative computed tomography (qCT). METHODS: This study was a prospective, multi-centre, single-blinded, observational study of EBV-LVR patients. Baseline and 3-month post intervention VQ SPECT and qCT were performed. The target lobe was chosen using qCT and planar VQ report (CTTL) whilst blinded to VQDI. Post EBV-LVR, our nuclear physician, blinded to CTTL, selected a target lobe using deidentified VQDI (VQDITL). Inter-rater agreement between CTTL and VQDITL was calculated by Kappa statistic. Treatment outcomes were analysed with a linear mixed-effects model. RESULTS: There was a high concordance between CTTL and VQDITL in 16 patients (89%, Kappa statistic = 0.85). Post EBV-LVR, our subjects showed significant changes in FEV1 (mean difference [MD] +150 mL, p < 0.001), target lobe volume reduction (MD -973 mL, p < 0.001), residual volume (MD -800 mL, p < 0.001), and St. George's Respiratory Questionnaire score (MD -11, p = 0.001). Improvements in 6-minute walk distances did not reach statistical significance. CONCLUSION: In this study of treatment responders, EBV-LVR target lobe selection using VQDI concurs with qCT and thus supports its value for this purpose. It complements qCT and may potentially be of synergistic value especially in homogenous emphysema.
BACKGROUND: Quantitative planar ventilation-perfusion (VQ) has a complementary role in target lobe selection for endobronchial valve lung volume reduction (EBV-LVR), especially in homogenous disease. We investigated a novel method of lung lobar quantitation using VQ single-photon emission computed tomography (SPECT) with computed tomography (CT) to generate a parameter called the ventilation-perfusion differential index (VQDI). AIM: The aim of this study was to validate VQDI as a parameter for target lobe selection in EBV-LVR against the gold standard test of quantitative computed tomography (qCT). METHODS: This study was a prospective, multi-centre, single-blinded, observational study of EBV-LVR patients. Baseline and 3-month post intervention VQ SPECT and qCT were performed. The target lobe was chosen using qCT and planar VQ report (CTTL) whilst blinded to VQDI. Post EBV-LVR, our nuclear physician, blinded to CTTL, selected a target lobe using deidentified VQDI (VQDITL). Inter-rater agreement between CTTL and VQDITL was calculated by Kappa statistic. Treatment outcomes were analysed with a linear mixed-effects model. RESULTS: There was a high concordance between CTTL and VQDITL in 16 patients (89%, Kappa statistic = 0.85). Post EBV-LVR, our subjects showed significant changes in FEV1 (mean difference [MD] +150 mL, p < 0.001), target lobe volume reduction (MD -973 mL, p < 0.001), residual volume (MD -800 mL, p < 0.001), and St. George's Respiratory Questionnaire score (MD -11, p = 0.001). Improvements in 6-minute walk distances did not reach statistical significance. CONCLUSION: In this study of treatment responders, EBV-LVR target lobe selection using VQDI concurs with qCT and thus supports its value for this purpose. It complements qCT and may potentially be of synergistic value especially in homogenous emphysema.
Authors: Arschang Valipour; Dirk-Jan Slebos; Felix Herth; Kaid Darwiche; Manfred Wagner; Joachim H Ficker; Christoph Petermann; Ralf-Harto Hubner; Franz Stanzel; Ralf Eberhardt Journal: Am J Respir Crit Care Med Date: 2016-11-01 Impact factor: 21.405
Authors: Arschang Valipour; Pallav L Shah; Wolfgang Gesierich; Ralf Eberhardt; Greg Snell; Charlie Strange; Robert Barry; Avina Gupta; Erik Henne; Sourish Bandyopadhyay; Philippe Raffy; Youbing Yin; Juerg Tschirren; Felix J F Herth Journal: Respiration Date: 2015-10-03 Impact factor: 3.580
Authors: Frank C Sciurba; Armin Ernst; Felix J F Herth; Charlie Strange; Gerard J Criner; Charles H Marquette; Kevin L Kovitz; Richard P Chiacchierini; Jonathan Goldin; Geoffrey McLennan Journal: N Engl J Med Date: 2010-09-23 Impact factor: 91.245
Authors: M A Puhan; D Chandra; Z Mosenifar; A Ries; B Make; N N Hansel; R A Wise; F Sciurba Journal: Eur Respir J Date: 2010-08-06 Impact factor: 16.671
Authors: Karin Klooster; Nick H T ten Hacken; Jorine E Hartman; Huib A M Kerstjens; Eva M van Rikxoort; Dirk-Jan Slebos Journal: N Engl J Med Date: 2015-12-10 Impact factor: 91.245
Authors: Christian Thomsen; Dorothea Theilig; Dominik Herzog; Alexander Poellinger; Felix Doellinger; Nils Schreiter; Vera Schreiter; Dirk Schürmann; Bettina Temmesfeld-Wollbrueck; Stefan Hippenstiel; Norbert Suttorp; Ralf-Harto Hubner Journal: Int J Chron Obstruct Pulmon Dis Date: 2016-06-09